LEXX
USDLexaria Bioscience Corp. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$0.990
Kõrge
$1.137
Madal
$0.990
Maht
0.17M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
24.7M
Tööstusharu
Biotehnoloogia
Riik
Canada
Kauplemisstatistika
Keskmine maht
0.57M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Lexaria Bioscience Corp. Provides Strategic Update
Strategic Business Development Advisory Firm Engaged To Support New Business Development ActivitiesLexaria Awarded 4 New Patents KELOWNA, BC / ACCESS Newswire / October 9, 2025 / Lexaria Bioscience Corp.
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
KELOWNA, BC / ACCESS Newswire / September 29, 2025 / Lexaria Bioscience Corp.
Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
KELOWNA, BC / ACCESS Newswire / September 26, 2025 / Lexaria Bioscience Corp. ) , a global innovator in drug delivery platforms, today announced that it
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
Enhanced Brain Biodistribution of GLP-1 Drugs May Be Related to Improvements in Safety and Efficacy KELOWNA, BC / ACCESS Newswire / September 19, 2025 / Lexaria Bioscience Corp. (the
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.